Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree Justin M. Haseltine, BSE,

Slides:

Advertisements

Similar presentations

Management of independent motion between multiple targets in lung cancer radiation therapy Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.

Advertisements

Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer Shervin M. Shirvani, MD, Ann.

Effect of variations in atelectasis on tumor displacement during radiation therapy for locally advanced lung cancer Nathan Tennyson, MD, Elisabeth Weiss,

Hiral P. Fontanilla, MD, Ann H. Klopp, MD, PhD, Mary E

Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.

Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer Shervin M. Shirvani, MD, Ann.

Should we irradiate a brain tumor in a patient with parkinsonism

RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1- 3) spine metastases: Phase 2 results Samuel Ryu, MD, Stephanie L.

Clinical evaluation of interfractional variations for whole breast radiotherapy using 3- dimensional surface imaging Amish P. Shah, PhD, Tomas Dvorak,

Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization

Dawn Owen, MD, PhD, Nadia N. Laack, MD, MSc, Charles S

Gastric perforation following stereotactic body radiation therapy of hepatic metastasis from colon cancer Matthew J. Furman, MD, Giles F. Whalen, MD,

Andreas Rimner, MD, Daniel R. Gomez, MD, Abraham J

Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary Lawrence B. Marks, MD, Robert.

Brenda G. Clark, PhD, Robert J

Required target margins for image-guided lung SBRT: Assessment of target position intrafraction and correction residuals Chirag Shah, MD, Larry L. Kestin,

Safety of differential radiation dosing in lymph node positive necks treated with IMRT Stephen Sozio, MBS, Zorimar Rivera-Núñez, PhD, Omar Mahmoud, MD,

Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer Nancy El-Bared, MD,

Tumor Regression and Positional Changes in Non-small Cell Lung Cancer During Radical Radiotherapy Gerald Lim, MD, Andrea Bezjak, MD, CM, MSc, Jane Higgins,

Dosimetric comparison of 3-dimensional conformal radiation therapy and intensity modulated radiation therapy and impact of setup errors in lower limb.

Should we irradiate a brain tumor in a patient with parkinsonism

Central3D: A Computer Tool to Help Clinicians Differentiate Central and Peripheral Lung Tumors Dominique Mathieu, MD MSc, Vincent Cousineau Daoust, MSc,

Use of standardized uptake value thresholding for target volume delineation in pediatric Hodgkin lymphoma Amanda J. Walker, MD, Alin Chirindel, MD, Robert.

Phantom Verification of AAA and Acuros Dose Calculations for Lung Cancer: Do Tumor Size and Regression Matter? Satomi Shiraishi, PhD, Luis E. Fong de.

Use of Stereotactic Ablative Radiotherapy (SABR) in Non–Small Cell Lung Cancer Measuring More Than 5 cm Hilâl Tekatli, MD, Saar van ’t Hof, MD, Esther.

Eliminating Daily Shifts, Tattoos, and Skin Marks: Streamlining Isocenter Localization With Treatment Plan Embedded Couch Values for External Beam Radiation.

Impact of radiotherapy dose on dentition breakdown in head and neck cancer patients Mary P. Walker, DDS, PhD, Brian Wichman, MS, An-Lin Cheng, PhD, James.

Action Levels on Dose and Anatomic Variation for Adaptive Radiation Therapy Using Daily Offline Plan Evaluation: Preliminary Results Baoshe Zhang, PhD,

Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.

American Society for Radiation Oncology's Performance Assessment for the Advancement of Radiation Oncology Treatment: A practical approach for informing.

Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent.

Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection Shalini Garg, MD,

Intramedullary Reactive Fibrosis as Mimic of Prostate Cancer Bone Metastasis on 11C- Choline Positron Emission and Computed Tomography Tyler Trump, BS,

Kiran Devisetty, MD, Joseph K. Salama, MD Journal of Thoracic Oncology

Efficacy of fiducial marker-based image-guided radiation therapy in prostate tomotherapy and potential dose coverage improvement using a patient positioning.

ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer Xiaoying Liang, PhD, Dandan Zheng, PhD, Maria Mamalui-Hunter,

Ellen Kim, MD, MPH, Siran Koroukian, PhD, Charles R. Thomas, MD

Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy Todd.

A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer Christopher.

Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma Fauzia Shaikh, MD, Marjorie G. Zauderer,

Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center

Effect of Daily and Every Other Day Stereotactic Body Radiation Therapy Schedules on Treatment-Related Fatigue in Patients With Hepatocellular Carcinoma

Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival after Stereotactic Body Radiation Therapy for Lung Cancer Nami.

“The Best-Laid Plans … Often go Awry …”

An Editorial Note: The Long Arm of Practical Radiation Oncology

The role of positron emission tomography for non-small cell lung cancer Albert J. Chang, MD, PhD, Farrokh Dehdashti, MD, Jeffrey D. Bradley, MD Practical.

Burnout and Resiliency in Canadian Oncology Residents: A Nationwide Resident and Program Director Survey Hannah Dahn, MD, Angela McGibbon, MD, David.

Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.

Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios as Prognostic Factors after Stereotactic Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer

Stereotactic Body Radiotherapy in Patients with Previous Pneumonectomy: Safety and Efficacy Robert Thompson, MD, Meredith Giuliani, MBBS, Mei Ling Yap,

Proton SBRT for Medically Inoperable Stage I NSCLC

Khaled Adil, MD, Marija Popovic, PhD, Fabio L. Cury, MD, Sergio L

Stereotactic Body Radiation Therapy for Primary Lung Cancers >3 Centimeters John J. Cuaron, MD, Ellen D. Yorke, PhD, Amanda Foster, BA, Meier Hsu, MS,

Safety Profile Assessment: An online tool to gauge safety-critical performance in radiation oncology Peter Dunscombe, PhD, Derek Brown, PhD, Holly Donaldson,

Intrafraction Motion Management of Renal Cell Carcinoma With Magnetic Resonance Imaging-Guided Stereotactic Body Radiation Therapy Fieke M. Prins, MD,

Stereotactic Body Radiation Therapy for the Treatment of Primary Cardiac Angiosarcoma Causing Hemodynamic Instability Prashant Gabani, MD, Benjamin W.

Pain Response Rates After Conventional Radiation Therapy for Bone Metastases in Prospective Nonrandomized Studies: A Systematic Review Tetsuo Saito,

Gaurav Marwaha, MD, Kevin L. Stephans, MD, Neil M

Using Smaller-Than-Standard Radiation Treatment Margins Does Not Change Survival Outcomes in Patients with High-Grade Gliomas Kripa Guram, BS, Mark Smith,

Andreas Rimner, MD, Kenneth E. Rosenzweig, MD

Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors Sean M. Parker, BS, R. Alfredo Siochi,

Hiral P. Fontanilla, MD, Ann H. Klopp, MD, PhD, Mary E

Todd J. Carpenter, MD, Kenneth E. Rosenzweig, MD

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Patterns-of-Care for Thoracic Stereotactic Body Radiotherapy among Practicing Radiation Oncologists in the United States Megan E. Daly, MD, Julian R.

Stereotactic Body Radiotherapy for Central Lung Tumors

A Review of First-Line Treatment for Small-cell Lung Cancer

Presentation transcript:

Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree Justin M. Haseltine, BSE, Andreas Rimner, MD, Daphna Y. Gelblum, MD, Ankit Modh, MD, Kenneth E. Rosenzweig, MD, Andrew Jackson, PhD, Ellen D. Yorke, PhD, Abraham J. Wu, MD Practical Radiation Oncology Volume 6, Issue 2, Pages e27-e33 (March 2016) DOI: 10.1016/j.prro.2015.09.012 Copyright © 2016 American Society for Radiation Oncology Terms and Conditions

Figure 1 Representative cross-sectional images of 4 tumors in patients with stereotactic body radiation therapy–related death and a patient with nonabutting tumor. Gross and planning target volume contours overlaid in red and green, respectively. Shown left to right, top to bottom: patient 1, patient 2, patient 3, patient 4, and nonabutting tumor patient. Practical Radiation Oncology 2016 6, e27-e33DOI: (10.1016/j.prro.2015.09.012) Copyright © 2016 American Society for Radiation Oncology Terms and Conditions

Figure 2 Grade 3+ toxicity-free survival for tumors ≤1 cm from the proximal bronchial tree (dashed line) versus ≥1 cm from the proximal bronchial tree (solid line). RT, radiation therapy. Practical Radiation Oncology 2016 6, e27-e33DOI: (10.1016/j.prro.2015.09.012) Copyright © 2016 American Society for Radiation Oncology Terms and Conditions